Overview of the quantity and quality of final UCB-NK products generated from enriched CD34<sup>+</sup> cells using static bags and single use bioreactors.

<p>The table summarizes the generation of UCB-NK cell therapy products generated in static bags (Donor 7, 8 and 9) or bioreactors cultures (Donor 10, 13, 15 and 16).</p>